ArticleHuman molecular genetics2018

Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types.

R W D Welford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.